Remdesivir row: COVID-19 drug prompts patent rules debate

Spreaker is getting a new look!

Preview our new listening experience personalized just for you.

Remdesivir row: COVID-19 drug prompts patent rules debate | 1 July 2020

Sky News Daily

00:00

27:46

Like Download

On this edition of the Sky News Daily podcast with Dermot Murnaghan, we examine the move by the US to buy up global supplies of the drug and its benefits.

We are joined by Dr Andrew Hill from the University of Liverpool, who also tells us about other drugs being repurposed to treat patients with the virus.

Plus, Hugh Milward from Microsoft and LinkedIn's Josh Graff discuss tectonic shifts in the jobs market as more firms announce cuts - and the launch of their global skills initiative: https://opportunity.linkedin.com

Credits:
Producer - Annie Joyce
Assistant producer - Sabah Choudhry

On this edition of the Sky News Daily podcast with Dermot Murnaghan, we examine the move by the US to buy up global supplies of the drug and its benefits. We are joined by Dr Andrew Hill from the University of Liverpool, who also tells us about other drugs being repurposed to treat patients with the virus. Plus, Hugh Milward from Microsoft and LinkedIn's Josh Graff discuss tectonic shifts in the jobs market as more firms announce cuts - and the launch of their global skills initiative: https://opportunity.linkedin.com Credits: Producer - Annie Joyce Assistant producer - Sabah Choudhry read more read less

3 years ago #coronavirus, #coronaviruspandemic, #covid, #covid-19, #covid19, #dexamethasone, #drandrewhill, #drug, #gilead, #gileadsciences, #jobcuts, #linkedin, #microsoft, #pharmaceutical, #podcast, #remdesivir, #science, #skills, #techonology, #virus

0 Comments

This episode has no messages yet. Be the first to write a message!

Spreaker is getting a new look!